medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2011, Number 1

Next >>

Ann Hepatol 2011; 10 (1)

Hepatology Highlights

Méndez-Sánchez N

Language: English
References: 11
Page: 3-4
PDF size: 26.50 Kb.


Text Extraction

Nonalcoholic fatty liver disease (NAFLD) in Brazil. Clinical and histological profile

Cotrim H, et al. This is an epidemiological and clinical study carried out in Brazil. The authors studied 1280 patients from 16 Brazilian centers. The mean age of patients was 49.68 ± 13.59 years; 53.3% were males and 85% were asymptomatic. Hyperlipidemia was observed in 66.8% cases, obesity in 44.7%, overweight in 44.4%, diabetes in 22.7%, and toxins exposure in 10%. Metabolic syndrome was found in 41.3% cases. Elevated levels of ALT, AST and GGT were reported in 55.8%, 42.2% and 63.1% cases, respectively.


REFERENCES

  1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004; 40: 1387-95.

  2. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.

  3. Ethnic groups - Brazil http://www.nationsencyclopedia.com/ Americas/Brazil-ETHNIC-GROUPS.html#ixzz1AZUDrDZ8.

  4. Caldwell SH, Lee VD, Kleiner DE, Al-Osaimi AM, Argo CK, Northup PG, Berg CL. NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol 2009; 8: 346-52.

  5. Moller H, Mellemgaard A, and Lindvig K et al., Obesity and cancer risk: a Danish record-linkage study, Eur J Cancer 1994; 30: 344–350.

  6. Calle EE, Rodriguez C, and Walker-Thurmond K et al., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med 348 2003; 348: 1625–1638.

  7. Encuesta Nacional de Salud y Nutrición 2006, Instituto Nacional de Salud Pública, 2006,

  8. Andrade F. Estimating diabetes and diabetes-free life expectancy in Mexico and seven major cities in Latin America and the Caribbean. Pan Am J Public Health 2009;26:9–16.

  9. Trombetta M, Spiazzi G, Zoppini G, Muggeo M. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. Aliment Pharmacol Ther 2005; 22 Suppl 2: 24-7.

  10. Nishida T, Tsuji S, Tsujii M, et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol. 2006; 101: 70-5.

  11. Kobashi-Margáin RA, Gutiérrez-Grobe Y, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico. Ann Hepatol 2010; 9: 282-8.




2020     |     www.medigraphic.com